Pfizer breast cancer drug fails late-stage test

Name: Pfizer breast cancer drug fails late-stage test
Uploaded: 2020-10-09T15:36:14+00:00
Duration: P49S
Description: Pfizer said on Friday its cancer drug Ibrance did not meet the main goal in a late-stage trial in patients with a type of breast cancer. Conway G. Gittens has

Credit: Reuters Studio

Duration: 00:49s 09 Oct 2020 0 shares 3 views

Pfizer breast cancer drug fails late-stage test

Pfizer said on Friday its cancer drug Ibrance did not meet the main goal in a late-stage trial in patients with a type of breast cancer.

Conway G.

Gittens has more.

Pfizer breast cancer drug fails late-stage test

You might like